Cellular Internalization of Therapeutic Oligonucleotides by Peptide Amphiphile Nanofibers and Nanospheres

ACS Applied Materials and Interfaces

Volumn 8, Issue 18, 2016, Pages 11280-11287

  Mumcuoglu, Didem ^a   Sardan Ekiz, Melis ^a   Gunay, Gokhan ^a   Tekinay, Turgay ^b   Tekinay, Ayse B ^a   Guler, Mustafa O ^a  

^a BILKENT UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

glucose transporters; glycoconjugates; internalization; oligonucleotide delivery; peptide amphiphiles; self assembly

Indexed keywords

CYTOLOGY; DNA SEQUENCES; GLUCOSE; MOLECULAR BIOLOGY; NANOFIBERS; NANOSPHERES; NANOSYSTEMS; NUCLEIC ACIDS; OLIGONUCLEOTIDES; PEPTIDES; POLYPEPTIDES; SELF ASSEMBLY;

CELLULAR INTERNALIZATION; ENDOCYTOSIS PATHWAY; GLUCOSE METABOLISM; GLUCOSE TRANSPORTERS; GLUCOSE-CONJUGATION; GLYCOCONJUGATES; INTERNALIZATION; PEPTIDE AMPHIPHILES;

AMPHIPHILES;

CLATHRIN; NANOFIBER; NANOSPHERE; OLIGONUCLEOTIDE; PEPTIDE;

ENDOCYTOSIS; HUMAN;

CLATHRIN; ENDOCYTOSIS; HUMANS; NANOFIBERS; NANOSPHERES; OLIGONUCLEOTIDES; PEPTIDES;

EID: 84974622752     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.6b01526     Document Type: Article

References (55)

1. Kurreck, J. Therapeutic Oligonucleotides RSC Biomol. Sci. 2008, 0, 1-102 10.1039/9781847558275-00001
2. Bouchard, P.; Hutabarat, R.; Thompson, K. Discovery and Development of Therapeutic Aptamers Annu. Rev. Pharmacol. Toxicol. 2010, 50, 237-257 10.1146/annurev.pharmtox.010909.105547
3. Kole, R.; Krainer, A. R.; Altman, S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides Nat. Rev. Drug Discovery 2012, 11 (2) 125-140 10.1038/nrd3625
4. Bennett, C. F.; Swayze, E. E. RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform Annu. Rev. Pharmacol. Toxicol. 2010, 50, 259-293 10.1146/annurev.pharmtox.010909.105654
5. Patil, S. D.; Rhodes, D. G.; Burgess, D. J. DNA-Based Therapeutics and DNA Delivery Systems: A Comprehensive Review AAPS J. 2005, 7 (1) E61-E77 10.1208/aapsj070109
6. Juliano, R.; Bauman, J.; Kang, H.; Ming, X. Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides Mol. Pharmaceutics 2009, 6 (3) 686-695 10.1021/mp900093r
7. Huang, L.; Liu, Y. In Vivo Delivery of RNAi with Lipid-Based Nanoparticles Annu. Rev. Biomed. Eng. 2011, 13, 507-530 10.1146/annurev-bioeng-071910-124709
8. Ewert, K. K.; Zidovska, A.; Ahmad, A.; Bouxsein, N. F.; Evans, H. M.; McAllister, C. S.; Samuel, C. E.; Safinya, C. R. Cationic Liposome-Nucleic Acid Complexes for Gene Delivery and Silencing: Pathways and Mechanisms for Plasmid DNA and siRNA Top. Curr. Chem. 2010, 296, 191-226 10.1007/128-2010-70
9. Zhu, L.; Mahato, R. I. Lipid and Polymeric Carrier-Mediated Nucleic Acid Delivery Expert Opin. Drug Delivery 2010, 7 (10) 1209-1226 10.1517/17425247.2010.513969
10. Rosi, N. L.; Giljohann, D. A.; Thaxton, C. S.; Lytton-Jean, A. K. R.; Han, M. S.; Mirkin, C. A. Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation Science 2006, 312 (5776) 1027-1030 10.1126/science.1125559
11. McBain, S. C.; Yiu, H. H. P.; Dobson, J. Magnetic Nanoparticles for Gene and Drug Delivery Int. J. Nanomed. 2008, 3 (2) 169-180 10.2147/IJN.S1608
12. Zhu, S. G.; Xiang, J. J.; Li, X. L.; Shen, S. R.; Lu, H. B.; Zhou, J.; Xiong, W.; Zhang, B. C.; Nie, X. M.; Zhou, M.; Tang, K.; Li, G. Y. Poly(L-lysine)-Modified Silica Nanoparticles for the Delivery of Antisense Oligonucleotides Biotechnol. Appl. Biochem. 2004, 39, 179-187 10.1042/BA20030077
13. Simone, E. A.; Dziubla, T. D.; Muzykantov, V. R. Polymeric Carriers: Role of Geometry in Drug Delivery Expert Opin. Drug Delivery 2008, 5 (12) 1283-1300 10.1517/17425240802567846
14. Shang, L.; Nienhaus, K.; Nienhaus, G. U. Engineered Nanoparticles Interacting with Cells: Size Matters J. Nanobiotechnol. 2014, 12, 5 10.1186/1477-3155-12-5
15. Macheda, M. L.; Rogers, S.; Best, J. D. Molecular and Cellular Regulation of Glucose Transporter (GLUT) Proteins in Cancer J. Cell. Physiol. 2005, 202 (3) 654-662 10.1002/jcp.20166
16. Vander Heiden, M. G.; Cantley, L. C.; Thompson, C. B. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation Science 2009, 324 (5930) 1029-1033 10.1126/science.1160809
17. Warburg, O. On the Origin of Cancer Cells Science 1956, 123 (3191) 309-314 10.1126/science.123.3191.309
18. Hanahan, D.; Weinberg, R. A. Hallmarks of Cancer: The Next Generation Cell 2011, 144 (5) 646-674 10.1016/j.cell.2011.02.013
19. Krzeslak, A.; Wojcik-Krowiranda, K.; Forma, E.; Jozwiak, P.; Romanowicz, H.; Bienkiewicz, A.; Brys, M. Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers Pathol. Oncol. Res. 2012, 18 (3) 721-728 10.1007/s12253-012-9500-5
20. Chan, D. A.; Sutphin, P. D.; Nguyen, P.; Turcotte, S.; Lai, E. W.; Banh, A.; Reynolds, G. E.; Chi, J. T.; Wu, J.; Solow-Cordero, D. E.; Bonnet, M.; Flanagan, J. U.; Bouley, D. M.; Graves, E. E.; Denny, W. A.; Hay, M. P.; Giaccia, A. J. Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality Sci. Transl. Med. 2011, 3 (94) 94ra70 10.1126/scitranslmed.3002394
21. Yun, J.; Rago, C.; Cheong, I.; Pagliarini, R.; Angenendt, P.; Rajagopalan, H.; Schmidt, K.; Willson, J. K.; Markowitz, S.; Zhou, S.; Diaz, L. A., Jr.; Velculescu, V. E.; Lengauer, C.; Kinzler, K. W.; Vogelstein, B.; Papadopoulos, N. Glucose Deprivation Contributes to The Development of KRAS Pathway Mutations in Tumor Cells Science 2009, 325 (5947) 1555-1559 10.1126/science.1174229
22. Grover-McKay, M.; Walsh, S. A.; Seftor, E. A.; Thomas, P. A.; Hendrix, M. J. Role for Glucose Transporter 1 Protein in Human Breast Cancer Pathol. Oncol. Res. 1998, 4 (2) 115-120 10.1007/BF02904704
23. Calvo, M. B.; Figueroa, A.; Pulido, E. G.; Campelo, R. G.; Aparicio, L. A. Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy Int. J. Endocrinol. 2010, 2010, 1 10.1155/2010/205357
24. Casneuf, V. F.; Fonteyne, P.; Van Damme, N.; Demetter, P.; Pauwels, P.; de Hemptinne, B.; De Vos, M.; Van de Wiele, C.; Peeters, M. Expression of SGLT1, Bcl-2 and p53 in Primary Pancreatic Cancer Related to Survival Cancer Invest. 2008, 26 (8) 852-859 10.1080/07357900801956363
25. Ishikawa, N.; Oguri, T.; Isobe, T.; Fujitaka, K.; Kohno, N. SGLT Gene Expression in Primary Lung Cancers and Their Metastatic Lesions Jpn. J. Cancer Res. 2001, 92 (8) 874-879 10.1111/j.1349-7006.2001.tb01175.x
26. Briasoulis, E.; Judson, I.; Pavlidis, N.; Beale, P.; Wanders, J.; Groot, Y.; Veerman, G.; Schuessler, M.; Niebch, G.; Siamopoulos, K.; Tzamakou, E.; Rammou, D.; Wolf, L.; Walker, R.; Hanauske, A. Phase I Trial of 6-h Infusion of Glufosfamide, a New Alkylating Agent with Potentially Enhanced Selectivity for Tumors that Overexpress Transmembrane Glucose Transporters: A Study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group J. Clin. Oncol. 2000, 18 (20) 3535-3544
27. Fu, Y.; Li, S.; Zu, Y.; Yang, G.; Yang, Z.; Luo, M.; Jiang, S.; Wink, M.; Efferth, T. Medicinal Chemistry of Paclitaxel and Its Analogues Curr. Med. Chem. 2009, 16 (30) 3966-3985 10.2174/092986709789352277
28. Cao, J.; Cui, S.; Li, S.; Du, C.; Tian, J.; Wan, S.; Qian, Z.; Gu, Y.; Chen, W. R.; Wang, G. Targeted Cancer Therapy with a 2-deoxyglucose-Based Adriamycin Complex Cancer Res. 2013, 73 (4) 1362-1373 10.1158/0008-5472.CAN-12-2072
29. Amanlou, M.; Heidari, Z.; Siadat, S. D.; Aghasadeghi, M. R.; Ghorbani, M.; Ebrahimi, S. E.; Sadat, S. M.; Hajmohammadi, M.; Arabzadeh, A. J.; Hekmat, S.; Alaei-Beirami, M.; Saraji, A. A.; Moghaddam, H. F.; Alavidjeh, M. S.; Delbaz, S. A.; Dashtbani-Roozbehani, A.; Ardestani, M. S. Nanosized Tamoxifen-Porphyrin-Glucose [TPG] Conjugate: Novel Selective Anti-Breast-Cancer Agent, Synthesis and In Vitro Evaluations Med. Chem. 2013, 9 (4) 526-538 10.2174/1573406411309040006
30. Jain, K.; Kesharwani, P.; Gupta, U.; Jain, N. K. A Review of Glycosylated Carriers for Drug Delivery Biomaterials 2012, 33 (16) 4166-4186 10.1016/j.biomaterials.2012.02.033
31. Calvaresi, E. C.; Hergenrother, P. J. Glucose Conjugation for the Specific Targeting and Treatment of Cancer Chem. Sci. 2013, 4 (6) 2319-2333 10.1039/c3sc22205e
32. Wang, J.; Yin, C.; Tang, G.; Lin, X.; Wu, Q. Glucose-Functionalized Multidrug-Conjugating Nanoparticles Based on Amphiphilic Terpolymer with Enhanced Anti-Tumorous Cell Cytotoxicity Int. J. Pharm. 2013, 441 (1-2) 291-298 10.1016/j.ijpharm.2012.11.030
33. Yin, L. G.; Dalsin, M. C.; Sizovs, A.; Reineke, T. M.; Hillmyer, M. A. Glucose-Functionalized, Serum-Stable Polymeric Micelles from the Combination of Anionic and RAFT Polymerizations Macromolecules 2012, 45 (10) 4322-4332 10.1021/ma300218n
34. Bulut, S.; Erkal, T. S.; Toksoz, S.; Tekinay, A. B.; Tekinay, T.; Guler, M. O. Slow Release and Delivery of Antisense Oligonucleotide Drug by Self-Assembled Peptide Amphiphile Nanofibers Biomacromolecules 2011, 12 (8) 3007-3014 10.1021/bm200641e
35. Guler, M. O.; Claussen, R. C.; Stupp, S. I. Encapsulation of Pyrene within Self-Assembled Peptide Amphiphile Nanofibers J. Mater. Chem. 2005, 15 (42) 4507-4512 10.1039/b509246a
36. Mumcuoglu, D.; Sardan, M.; Tekinay, T.; Guler, M. O.; Tekinay, A. B. Oligonucleotide Delivery with Cell Surface Binding and Cell Penetrating Peptide Amphiphile Nanospheres Mol. Pharmaceutics 2015, 12 (5) 1584-1591 10.1021/acs.molpharmaceut.5b00007
37. Whitmore, L.; Wallace, B. A. Protein Secondary Structure Analyses from Circular Dichroism Spectroscopy: Methods and Reference Databases Biopolymers 2008, 89 (5) 392-400 10.1002/bip.20853
38. Sadler, K.; Eom, K. D.; Yang, J. L.; Dimitrova, Y.; Tam, J. P. Translocating Proline-Rich Peptides from the Antimicrobial Peptide Bactenecin 7 Biochemistry 2002, 41 (48) 14150-14157 10.1021/bi026661l
39. Yoon, Y.-R.; Lim, Y.-b.; Lee, E.; Lee, M. Self-Assembly of a Peptide Rod-Coil: A Polyproline Rod and a Cell-Penetrating Peptide Tat Coil Chem. Commun. 2008, 16, 1892-1894 10.1039/b719868j
40. Hu, X.; Hu, J.; Tian, J.; Ge, Z.; Zhang, G.; Luo, K.; Liu, S. Polyprodrug Amphiphiles: Hierarchical Assemblies for Shape-Regulated Cellular Internalization, Trafficking, and Drug Delivery J. Am. Chem. Soc. 2013, 135 (46) 17617-17629 10.1021/ja409686x
41. Lim, Y. b.; Lee, E.; Lee, M. Controlled Bioactive Nanostructures from Self-Assembly of Peptide Building Blocks Angew. Chem., Int. Ed. 2007, 46 (47) 9011-9014 10.1002/anie.200702732
42. Moyer, T. J.; Kassam, H. A.; Bahnson, E. S.; Morgan, C. E.; Tantakitti, F.; Chew, T. L.; Kibbe, M. R.; Stupp, S. I. Shape-Dependent Targeting of Injured Blood Vessels by Peptide Amphiphile Supramolecular Nanostructures Small 2015, 11 (23) 2750-2755 10.1002/smll.201403429
43. Mammadov, R.; Cinar, G.; Gunduz, N.; Goktas, M.; Kayhan, H.; Tohumeken, S.; Topal, A. E.; Orujalipoor, I.; Delibasi, T.; Dana, A. Virus-Like Nanostructures for Tuning Immune Response Sci. Rep. 2015, 5, 16728 10.1038/srep16728
44. Iversen, T. G.; Skotland, T.; Sandvig, K. Endocytosis and Intracellular Transport of Nanoparticles: Present Knowledge and Need for Future Studies Nano Today 2011, 6 (2) 176-185 10.1016/j.nantod.2011.02.003
45. Chithrani, B. D.; Chan, W. C. W. Elucidating the Mechanism of Cellular Uptake and Removal of Protein-Coated Gold Nanoparticles of Different Sizes and Shapes Nano Lett. 2007, 7 (6) 1542-1550 10.1021/nl070363y
46. Goto, Y.; Kida, K.; Kaino, Y.; Ito, T.; Matsuda, H. Inhibitory Effect of Amiloride on Glucose Transport in Isolated Rat Adipocytes Diabetes Res. Clin. Pract. 1993, 20 (1) 1-5 10.1016/0168-8227(93)90015-W
47. ZamoraLeon, S. P.; Golde, D. W.; Concha, I. I.; Rivas, C. I.; DelgadoLopez, F.; Baselga, J.; Nualart, F.; Vera, J. C. Expression of the Fructose Transporter GLUT5 in Human Breast Cancer Proc. Natl. Acad. Sci. U. S. A. 1996, 93 (5) 1847-1852 10.1073/pnas.93.5.1847
48. Janku, F.; Huang, H. J.; Angelo, L. S.; Kurzrock, R. A Kinase-Independent Biological Activity for Insulin Growth Factor-1 Receptor (IGF-1R): Implications for Inhibition of the IGF-1R Signal Oncotarget 2013, 4 (3) 463-473 10.18632/oncotarget.886
49. Ehrenkranz, J. R. L.; Lewis, N. G.; Kahn, C. R.; Roth, J. Phlorizin: A Review Diabetes/Metab. Res. Rev. 2005, 21 (1) 31-38 10.1002/dmrr.532
50. Estensen, R. D.; Plagemann, P. G. Cytochalasin B: Inhibition of Glucose and Glucosamine Transport Proc. Natl. Acad. Sci. U. S. A. 1972, 69 (6) 1430-1434 10.1073/pnas.69.6.1430
51. Augustin, R. The Protein Family of Glucose Transport Facilitators: It's Not Only About Glucose After All IUBMB Life 2010, 62 (5) 315-333 10.1002/iub.315
52. Rogers, S.; Macheda, M. L.; Docherty, S. E.; Carty, M. D.; Henderson, M. A.; Soeller, W. C.; Gibbs, E. M.; James, D. E.; Best, J. D. Identification of a Novel Glucose Transporter-Like Protein-GLUT-12 Am. J. Physiol. Endocrinol. Metab. 2002, 282 (3) E733-E738
53. Moros, M.; Hernáez, B.; Garet, E.; Dias, J. T.; Sáez, B.; Grazú, V.; González-Fernández, á.; Alonso, C.; de la Fuente, J. s. M. Monosaccharides versus PEG-Functionalized NPs: Influence in the Cellular Uptake ACS Nano 2012, 6 (2) 1565-1577 10.1021/nn204543c
54. Jiang, X.; Xin, H.; Ren, Q.; Gu, J.; Zhu, L.; Du, F.; Feng, C.; Xie, Y.; Sha, X.; Fang, X. Nanoparticles of 2-Deoxy-D-Glucose Functionalized Poly (ethylene glycol)-co-poly (trimethylene carbonate) for Dual-Targeted Drug Delivery in Glioma Treatment Biomaterials 2014, 35 (1) 518-529 10.1016/j.biomaterials.2013.09.094
55. Wang, Z.; Tiruppathi, C.; Minshall, R. D.; Malik, A. B. Size and Dynamics of Caveolae Studied Using Nanoparticles in Living Endothelial Cells ACS Nano 2009, 3 (12) 4110-4116 10.1021/nn9012274